Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors.
Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates.
Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy.
Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
Immunodiscordant responses to HAART--mechanisms and consequences.
A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1.
RECall for automated genotypic tropism testing.